SETD2 and cancer: To understand how Setd2 deficiency increases chromatin accessibility to induce the expression of KRAS signature, we first focused on Etv1, one of the transcription factors downstream of ERK signaling and a well-defined oncogene in multiple cancer types (31, 32).